New Obesity Education Program To Premiere At American College of Physicians (ACP) Annual Meeting

 New Obesity Education Program To Premiere At American College of Physicians
                             (ACP) Annual Meeting


PR Newswire

MOUNTAIN VIEW, Calif., April 10, 2013

MOUNTAIN VIEW, Calif., April 10, 2013 /PRNewswire/ --A new educational
program, Excess Weight and Your Health: A Guide to Effective, Healthy Weight
Loss, developed by the Obesity Action Coalition (OAC) and the American College
of Physicians (ACP), will be released today at Internal Medicine 2013, the
annual scientific meeting of the ACP. The booklet and DVD program, funded by
an educational grant from VIVUS, Inc., focuses on encouraging patients to
speak with their physicians about obesity and explores the reasons individuals
gain excess weight, as well as effective methods for losing weight and keeping
it off.

The Excess Weight and Your Health program discusses how people can make better
food choices and build more physical activity into their lives, while
explaining available medical treatments and surgical options for those
struggling with excess weight. The program can be viewed online and ordered
free of charge by healthcare professionals at

"Obesity is a complex condition and we need tools like this program that help
encourage primary care physicians' communication with patients to find the
best treatment plans to achieve the benefits of a healthy weight," said David
L. Bronson, MD, FACP, president of ACP.

"Losing weight is often more complicated than just eating less and exercising
more," said Joe Nadglowski, OAC president and CEO. "We are proud to partner
with ACP, one of the largest physician groups in the United States, to
encourage healthcare providers to be proactive in having conversations with
their patients about the health consequences of excess weight and obesity and
how they can safely and effectively manage their weight."

Internal Medicine 2013 takes place April 11-13, 2013 at the Moscone Center in
San Francisco and features more than 6,000 internal medicine physicians,
subspecialists, medical students and allied health professionals from around
the world.


VIVUS is a biopharmaceutical company commercializing and developing
innovative, next-generation therapies to address unmet needs in obesity, sleep
apnea, diabetes and sexual health. For more information about the company,
please visit

Certain statements in this press release are forward-looking within the
meaning of the Private Securities Litigation Reform Act of 1995. These
statements may be identified by the use of forward-looking words such as
"anticipate," "believe," "forecast," "estimate," "expect," "intend," "likely,"
"may," "plan," "potential," "predict," "opportunity" and "should," among
others. There are a number of factors that could cause actual events to differ
materially from those indicated by such forward-looking statements. VIVUS does
not undertake an obligation to update or revise any forward-looking
statements. Investors should read the risk factors set forth in VIVUS' Form
10-K for the year ending December 31, 2012, and periodic reports filed with
the Securities and Exchange Commission.


Contact: VIVUS, Inc., Timothy E. Morris, Chief Financial Officer,; or Media Relations: GolinHarris, Ashley Buford,, (212) 373-6045; or Investor Relations: The Trout
Group, Brian Korb,, 646-378-2923
Press spacebar to pause and continue. Press esc to stop.